Zentalis Pharmaceuticals (ZNTL) EBIT (2019 - 2026)
Zentalis Pharmaceuticals' (ZNTL) quarterly EBIT came in at -$37.9 million in Q1 2026, up 17.03% year-on-year from -$32.3 million in Q1 2025, and down 1.24% quarter-over-quarter from -$37.4 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) EBIT (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' EBIT history runs 8 years deep, the most recent figure standing at -$37.9 million for Q1 2026.
- On a quarterly basis, EBIT rose 17.03% year-over-year to -$37.9 million in Q1 2026; TTM through Mar 2026 was -$145.0 million, a 31.6% increase from a year earlier, with the FY2025 full-year figure at -$152.8 million, up 20.08% from the prior year.
- EBIT eased to -$37.9 million in Q1 2026 per ZNTL's latest filing, from -$37.4 million in the prior quarter.
- Across five years, EBIT topped out at -$24.8 million in Q1 2024 and bottomed at -$103.9 million in Q2 2023.
- The 5-year median for EBIT is -$51.8 million (2022), against an average of -$53.5 million.
- Across the five-year window, EBIT soared 61.87% in 2024 and plunged 84.22% in 2025, its largest moves.
- Year by year, EBIT stood at -$51.8 million in 2022, then slumped by 31.24% to -$67.9 million in 2023, then rose by 26.61% to -$49.8 million in 2024, then rose by 24.99% to -$37.4 million in 2025, then decreased by 1.24% to -$37.9 million in 2026.
- Per Business Quant, the three latest ZNTL EBIT figures stand at -$37.9 million (Q1 2026), -$37.4 million (Q4 2025), and -$33.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - | -37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.86 Mn |
| Dec 31, 2025 | -37.39 Mn |
| Sep 30, 2025 | -33.73 Mn |
| Jun 30, 2025 | -36.06 Mn |
| Mar 31, 2025 | -45.62 Mn |
| Dec 31, 2024 | -49.85 Mn |
| Sep 30, 2024 | -51.43 Mn |
| Jun 30, 2024 | -65.15 Mn |
| Mar 31, 2024 | -24.77 Mn |
| Dec 31, 2023 | -67.92 Mn |
| Sep 30, 2023 | -62.72 Mn |
| Jun 30, 2023 | -103.92 Mn |
| Mar 31, 2023 | -64.95 Mn |
| Dec 31, 2022 | -51.75 Mn |
| Sep 30, 2022 | -54.19 Mn |
| Jun 30, 2022 | -63.46 Mn |
| Mar 31, 2022 | -57.88 Mn |
| Dec 31, 2021 | -48.19 Mn |
| Sep 30, 2021 | -62.87 Mn |
| Jun 30, 2021 | -55.13 Mn |